Latest News and Press Releases
Want to stay updated on the latest news?
-
Strengthening of CPTx executive team with appointment of Edward Rebar, PhD, as Chief Scientific Officer. David Maier is appointed Chief Business Officer.
-
Oral presentation showing in vivo proof-of-principle of CPTx's immune-quiet, single-stranded DNA-based delivery platform.